ACUTE MYELOID LEUKEMIA: TREATMENT OVER 60-Reference-Cited by-同舟云学术

ACUTE MYELOID LEUKEMIA: TREATMENT OVER 60

Published:2002-03 Issue:1 Volume:6 Page:46-59
ISSN:1127-0020
Container-title:Reviews in Clinical and Experimental Hematology
language:en
Short-container-title:Rev Clin Exp Hematol

Author:

Buchner Thomas,Hiddemann Wolfgang,Berdel Wolfgang,Wormann Bernhard,Schoch Claudia,Loffler Helmut,Haferlach Torsten,Schumacher Andrea,Staib Peter,Balleisen Leopold,Gruneisen Andreas,Rasche Herbert,Aul Carlo,Heyll Axel,Lengfelder Eva,Ludwig Wolf-Dieter,Maschmeyer Georg,Eimermacher Hartmut,Karow Jochen,Frickhofen Norbert,Hirschmann Wolf-Dietrich,Sauerland Maria-Cristina,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1468-0734.2002.00059.x/fullpdf

Reference73 articles.

1. AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

2. 3 Second International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenetics2 : 89 -113 , 1980 .

3. CHROMOSOME CHANGES IN ACUTE LEUKAEMIA

4. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology;Analytical Chemistry;2020-08-13

2. Targeted therapy with a selective BCL-2 inhibitor in older patients with acute myeloid leukemia;Hematology, Transfusion and Cell Therapy;2019-04

3. Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years;American Journal of Hematology;2017-08-17

4. Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post‐induction consolidation therapy;American Journal of Hematology;2016-11-08

5. Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia;Clinical Drug Investigation;2016-10-08